Special Issue "Novel Therapeutic Approaches in Inflammatory Bowel Diseases 3.0"
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 11533
Interests: preclinical pharmacology; inflammation; oxidative stress; natural products; flavonoids; cannabinoids; adenosine pathway; clinical pharmacology; pharmacogenetics
Special Issues, Collections and Topics in MDPI journals
Special Issue in Biomedicines: Novel Therapeutic Approaches in Inflammatory Bowel Diseases 2.0
Special Issue in International Journal of Molecular Sciences: New Insights into Adipose Tissue Metabolic Function and Dysfunction
Special Issue in International Journal of Molecular Sciences: New Insights in Natural Bioactive Compounds
Special Issue in International Journal of Molecular Sciences: New Insights into Adipose Tissue Metabolic Function and Dysfunction 2.0
Special Issue in International Journal of Molecular Sciences: New Insights in Natural Bioactive Compounds 2.0
Inflammatory bowel diseases (IBDs) such as Crohn’s disease and ulcerative colitis are chronic diseases of the gastrointestinal tract characterized by inflammation of the enteric wall, abdominal pain, diarrhea, bleeding, and malabsorption.
Conventional therapies for IBD include anti-inflammatory drugs, corticosteroids, thiopurines, methotrexate, and anti-tumor necrosis factor agents. The long-term use of these drugs can induce severe side effects with a negative impact on patients’ quality of life. For this reason, there is great interest in finding new therapeutic strategies with fewer side effects for the treatment of IBDs.
The purpose of this Special Issue is to publish original research papers and/or relevant updates of literature data on the beneficial effects of novel and safe treatments in gastrointestinal disorders.
Dr. Giovanni Pallio
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Crohn’s disease
- oxidative stress